Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: Prevention by rosiglitazone

Biochemical and Biophysical Research Communications

Volumn 311, Issue 2, 2003, Pages 372-379

  Lagathu, Claire ^a   Bastard, Jean Philippe ^a   Auclair, Martine ^a   Maachi, Mustapha ^a   Capeau, Jacqueline ^a   Caron, Martine ^a  

^a INSERM   (France)

Author keywords

Adipocyte; Cytokine; Insulin resistance; Interleukin 6; Thiazolidinedione

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CELL MARKER; FAS ANTIGEN; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INSULIN RECEPTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; PROTEIN AP2; PROTEIN KINASE B; RECEPTOR SUBUNIT; RECOMBINANT INTERLEUKIN 6; ROSIGLITAZONE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEIN 3; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; LIPOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0242299763     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.013     Document Type: Article

References (41)

1. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 148:2000;209-214.
2. Bastard J.P., Maachi M., Tran Van Nhieu J., Jardel C., Bruckert E., Grimaldi A., Robert J.J., Capeau J., Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87:2002;2084-2089.
3. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab. 86:2001;1154-1159.
4. Vozarova B., Weyer C., Hanson K., Tataranni P., Bogardus C., Pratley R. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9:2001;414-417.
5. Hotamisligil G., Shargill N., Spiegelman B. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259:1993;87-91.
6. Besedovsky H.O., Del Rey A. Metabolic and endocrine actions of interleukin-1. Effects on insulin-resistant animals. Ann. N. Y. Acad. Sci. 594:1990;214-221.
7. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85:2000;3338-3342.
8. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83:1998;847-850.
9. Muller S., Martin S., Koenig W., Hanifi-Moghaddam P., Rathmann W., Haastert B., Giani G., Illig T., Thorand B., Kolb H. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia. 45:2002;805-812.
10. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82:1997;4196-4200.
11. Flower L., Gray R., Pinkney J., Mohamed-Ali V. Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes. Cytokine. 21:2003;32-37.
12. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95:1995;2409-2415.
13. Sethi J., Hotamisligil G. The role of TNF alpha in adipocyte metabolism. Semin. Cell. Dev. Biol. 10:1999;19-29.
14. Path G., Bornstein S.R., Gurniak M., Chrousos G.P., Scherbaum W.A., Hauner H. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J. Clin. Endocrinol. Metab. 86:2001;2281-2288.
15. Greenberg A.S., Nordan R.P., McIntosh J., Calvo J.C., Scow R.O., Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res. 52:1992;4113-4116.
16. Tanaka T., Itoh H., Doi K., Fukunaga Y., Hosoda K., Shintani M., Yamashita J., Chun T.H., Inoue M., Masatsugu K., Sawada N., Saito T., Inoue G., Nishimura H., Yoshimasa Y., Nakao K. Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia. 42:1999;702-710.
17. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.
18. Emanuelli B., Peraldi P., Filloux C., Sawka-Verhelle D., Hilton D., Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275:2000;15985-15991.
19. Starr R., Willson T., Viney E., Murray L., Rayner J., Jenkins B., Gonda T., Alexander W., Metcalf D., Nicola N., Hilton D. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
20. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., Hotamisligil G.S., Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem. 276:2001;47944-47949.
21. Senn J., Klover P., Nowak I., Zimmers T., Koniaris L., Furlanetto R., Mooney R. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278:2003;13740-13746.
22. Senn J.J., Klover P.J., Nowak I.A., Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 51:2002;3391-3399.
23. Hauner H. The mode of action of thiazolidinediones. Diabetes Metab. Res. Rev. 18:2002;S10-5.
24. Spiegelman B.M. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 47:1998;507-514.
25. Caron M., Auclair M., Vigouroux C., Glorian M., Forest C., Capeau J. The HIV protease inhibitor indinavir impairs sterol regulatory element- binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes. 50:2001;1378-1388.
26. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280:2001;E745-E751.
27. Klouche M., Bhakdi S., Hemmes M., Rose-John S. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J. Immunol. 163:1999;4583-4589.
28. McTernan P.G., Harte A.L., Anderson L.A., Green A., Smith S.A., Holder J.C., Barnett A.H., Eggo M.C., Kumar S. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes. 51:2002;1493-1498.
29. Cowherd R.M., Lyle R.E., McGehee R.E. Jr. Molecular regulation of adipocyte differentiation. Semin. Cell Dev. Biol. 10:1999;3-10.
30. Wu Z., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., McKeon C., Darlington G.J., Spiegelman B.M. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell. 3:1999;151-158.
31. Kaestner K.H., Christy R.J., Lane M.D. Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. USA. 87:1990;251-255.
32. Le Lay S., Lefrere I., Trautwein C., Dugail I., Krief S. Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target. J. Biol. Chem. 277:2002;35625-35634.
33. Soukas A., Socci N.D., Saatkamp B.D., Novelli S., Friedman J.M. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J. Biol. Chem. 276:2001;34167-34174.
34. Amri E.Z., Bertrand B., Ailhaud G., Grimaldi P. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J. Lipid Res. 32:1991;1449-1456.
35. Gustafson B., Jack M.M., Cushman S.W., Smith U. Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochem. Biophys. Res. Commun. 308:2003;933-939.
36. Peraldi P., Filloux C., Emanuelli B., Hilton D., Van Obberghen E. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase. J. Biol. Chem. 276:2001;24614-24620.
37. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 271:1996;665-668.
38. Alvarez B., Quinn L.S., Busquets B., Quiles M.T., Lopez-Soriano F.J., Argiles J.M. Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. Biochim. Biophys. Acta. 1542:2002;66-72.
39. Streetz K.L., Wustefeld T., Klein C., Manns M.P., Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell. Mol. Biol. (Noisy-le-grand). 47:2001;661-673.
40. Grunfeld C., Feingold K.R. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy. 3:1991;143-158.
41. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., Paschke R. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 301:2003;1045-1050.